UBS O'Connor’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

UBS O'Connor’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,925,000	Closed	-$70.5M	–	731
2023 Q1	$70.5M	Buy	+2,925,000	New	+$36.7M	1.67%	12
2019 Q4	–	Sell	-40,000	Closed	-$273K	–	375
2019 Q3	$273K	Buy	+40,000	New	+$404K	0.01%	255

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

UBS O'Connor's PRVB Position: Q2 2023 in Review

UBS O'Connor sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 2,925,000 shares — an estimated $70.5M sold.

UBS O'Connor first reported a position in PRVB in Q3 2019 and held it in 2 quarters. The position peaked at $70.5M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

UBS O'Connor reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
UBS O'Connor sold 2,925,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $70.5M.
UBS O'Connor first reported a position in Provention Bio, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
UBS O'Connor's Provention Bio, Inc. Common Stock position peaked at $70.5M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.